Autoantibodies in Sjogren's Syndrome

被引：135

作者：

Fayyaz, Anum ^{[1
,2
,3
]}

Kurien, Biji T. ^{[1
,2
,3
]}

Scofield, R. Hal ^{[1
,2
,3
]}

机构：

[1] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 Northeast,13th St, Oklahoma City, OK 73104 USA

[2] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Coll Med, 1000 N Lincoln Blvd, Oklahoma City, OK 73104 USA

[3] US Dept Vet Affairs Hosp, Med & Res Serv, 921 NE 13th St, Oklahoma City, OK 73104 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2016年 / 42卷 / 03期

关键词：

Sjogren's syndrome; Autoantibodies; Congenital heart block; CONGENITAL HEART-BLOCK; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CITRULLINATED PEPTIDE ANTIBODIES; ALPHA-FODRIN ANTIBODIES; ANTICENTROMERE ANTIBODIES; NEONATAL LUPUS; CLINICAL-SIGNIFICANCE; RHEUMATOID-FACTOR; ANTI-RO/SSA; CLASSIFICATION CRITERIA;

D O I：

10.1016/j.rdc.2016.03.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We compiled information on antibodies in Sjogren syndrome (SS), focusing more on clinical manifestations associated with anti-Ro/SSA and anti-La/SSB antibodies and studies regarding novel antibodies. We reviewed previous as well as most recent studies with the subject heading Sjogren in combination with antibodies and congenital heart block (CHB). Almost half of asymptomatic mothers giving birth to children with CHB ultimately develop Sjogren. We discussed studies concerning the presence of antibodies predating clinical manifestations of disease. Studies in the future are required to ascertain the pathogenic mechanisms associated with these antibodies and the specific clinical manifestation related to new autoantibodies.

引用

页码：419 / +

页数：17

共 50 条

[31] Towards the identification of novel autoantibodies in Sjogren's syndrome
Witte, T.
Engelke, F.
Ritter, J.
Doerner, T.
De Vita, S.
Goules, A. V.
Tzioufas, A. G.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 2395 - 2397
[32] Cholinoreceptor autoantibodies in Sjogren syndrome
Reina, S.
Orman, B.
Anaya, J. M.
Sterin-Borda, L.
Borda, E.
[J]. JOURNAL OF DENTAL RESEARCH, 2007, 86 (09) : 832 - 836
[33] Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjogren's Syndrome and Systemic Lupus Erythematosus
Rietveld, Anke
van den Hoogen, Luuk L.
Bizzaro, Nicola
Blokland, Sofie L. M.
Daehnrich, Cornelia
Gottenberg, Jacques-Eric
Houen, Gunnar
Johannsen, Nora
Mandl, Thomas
Meyer, Alain
Nielsen, Christoffer T.
Olsson, Peter
van Roon, Joel
Schlumberger, Wolfgang
van Engelen, Baziel G. M.
Saris, Christiaan G. J.
Pruijn, Ger J. M.
[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
[34] The epidemiology of Sjogren's syndrome
Patel, Ruchika
Shahane, Anupama
[J]. CLINICAL EPIDEMIOLOGY, 2014, 6 : 247 - 255
[35] Primary Sjogren's syndrome
Rischmueller, Maureen
Tieu, Joanna
Lester, Susan
[J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (01): : 189 - 220
[36] Investigation of novel autoantibodies in Sjogren’s syndrome utilizing Sera from the Sjogren’s international collaborative clinical alliance cohort
Lakshmanan Suresh
Kishore Malyavantham
Long Shen
Julian L Ambrus
[J]. BMC Ophthalmology, 15
[37] Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort
Suresh, Lakshmanan
Malyavantham, Kishore
Shen, Long
Ambrus, Julian L., Jr.
[J]. BMC OPHTHALMOLOGY, 2015, 15
[38] Autoantibodies and primary Sjogren's syndrome in a hypocitraturic stone population
Eriksson, P
Denneberg, T
Lundstrom, I
Skogh, T
Tiselius, HG
[J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1997, 31 (01): : 73 - 80
[39] Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome
Li, JC
Ha, YM
Kü, NY
Choi, SY
Lee, SJ
Oh, SB
Kim, JS
Lee, JH
Lee, EB
Song, YW
Park, K
[J]. LABORATORY INVESTIGATION, 2004, 84 (11) : 1430 - 1438
[40] Autoantibodies against α-fodrin in Sjogren's syndrome with neurological manifestations
De Seze, J
Dubucquoi, S
Fauchais, AL
Hachulla, E
Matthias, T
Lefranc, D
Hatron, PY
Vermersch, P
Witte, T
[J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (03) : 500 - 503

← 1 2 3 4 5 →